Dan Nardi, Chief Executive Officer at Reimagine Care, Co-founder at Zavier, shared a post on LinkedIn:
“It is something we’ve been saying for more than 2 years… the gap between supply and demand of healthcare delivery is growing, but Reimagine Care is solving that for Oncology Clinics and their Patients by combining Remi (our AI-based virtual assistant) and a remote clinical team in real time.
This article in MedCity News has highlighted the problem statement, but I’m convinced that the dots have been connected, and there is a very workable front door for cancer care that is powered by Reimagine Care. The impact is real, and we have data that proves it in multiple ways. Let me know if you want to learn more.”
Quote from the article:
‘The technology and infrastructure to support a new triage system already exists; we just haven’t connected the dots. The solution comes from combining scalable AI tools with clinical oversight to deliver smart, context-aware triage at scale. Imagine a patient describing their symptoms to a conversational AI interface that collects an initial history and notes potential red flags. That case is then asynchronously reviewed by a physician who has access to the patient’s health records and relevant data. In many cases, they’ll be able to direct the patient safely, whether to self-care, primary care, urgent care, or emergency care.’
Title: ChatGPT for Medical Use Is a Cry for Help. We Need Better Medical Triage
Authors: Rishi Khakhkhar, David Whitehead, Muthu Alagappan
Read the Full Article in MedCity News.
Douglas Flora, Executive Medical Director of Yung Family Cancer Center at St. Elizabeth Healthcare, President-Elect of the Association of Cancer Care Centers, and Editor in Chief of AI in Precision Oncology, shared this post, adding:
“Well said, Dan Nardi. Your national leadership in this conversation is important and appreciated! Keep pushing. Oncology needs solutions like yours.
Following Reimagine Care’s progress and cheering from Cincinnati. Patients need tools like yours to navigate these increasingly complex waters.”
More posts featuring Dan Nardi on OncoDaily.